These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4052520)

  • 21. The dexamethasone suppression test in depressed and non-depressed geriatric medical inpatients.
    Magni G; Schifano F; De Leo D; De Dominicis MG; Garbin A; Zangaglia O
    Acta Psychiatr Scand; 1986 May; 73(5):511-4. PubMed ID: 3751656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered plasma dexamethasone and cortisol suppressibility in patients with panic disorders.
    Carson SW; Halbreich U; Yeh CM; Goldstein S
    Biol Psychiatry; 1988 May; 24(1):56-62. PubMed ID: 3370278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Endocrinologic testing of alcoholics with depressive states--with special reference to the dexamethasone suppression test].
    Suwa K; Takano K; Nishijima K; Ishiguro T; Enomoto M
    Seishin Shinkeigaku Zasshi; 1983; 85(11):823-6. PubMed ID: 6677920
    [No Abstract]   [Full Text] [Related]  

  • 24. Dexamethasone suppression tests in patients with panic disorder.
    Lieberman JA; Brenner R; Lesser M; Coccaro E; Borenstein M; Kane JM
    Am J Psychiatry; 1983 Jul; 140(7):917-9. PubMed ID: 6859315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortisol response to clonidine in panic disorder: comparison with depressed patients and normal controls.
    Stein MB; Uhde TW
    Biol Psychiatry; 1988 Jul; 24(3):322-30. PubMed ID: 2840978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elucidation of neurobiology of anxiety disorders in children through pharmacological challenge tests and cortisol measurements: a systematic review.
    Garcia de Miguel B; Nutt DJ; Hood SD; Davies SJ
    J Psychopharmacol; 2012 Apr; 26(4):431-42. PubMed ID: 20643698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dimensions of depression and anxiety and the hypothalamo-pituitary-adrenal axis.
    Wardenaar KJ; Vreeburg SA; van Veen T; Giltay EJ; Veen G; Penninx BW; Zitman FG
    Biol Psychiatry; 2011 Feb; 69(4):366-73. PubMed ID: 21030010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Panic induced by carbon dioxide inhalation and lack of hypothalamic-pituitary-adrenal axis activation.
    Sinha SS; Coplan JD; Pine DS; Martinez JA; Klein DF; Gorman JM
    Psychiatry Res; 1999 May; 86(2):93-8. PubMed ID: 10397411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Memory disturbances and dexamethasone suppression test in major depression.
    Wauthy J; Ansseau M; von Frenckell R; Mormont C; Legros JJ
    Biol Psychiatry; 1991 Oct; 30(7):736-8. PubMed ID: 1958771
    [No Abstract]   [Full Text] [Related]  

  • 30. The neurobiological basis of mixed depression-anxiety states.
    Gulley LR; Nemeroff CB
    J Clin Psychiatry; 1993 Jan; 54 Suppl():16-9. PubMed ID: 8093884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cortisol as an indicator of hypothalmic-pitituary-adrenal axis dysregulation in patients with panic disorder: a literature review.
    Jakuszkowiak-Wojten K; Landowski J; Wiglusz MS; Cubała WJ
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S445-51. PubMed ID: 26417813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.
    Vreeburg SA; Hoogendijk WJ; van Pelt J; Derijk RH; Verhagen JC; van Dyck R; Smit JH; Zitman FG; Penninx BW
    Arch Gen Psychiatry; 2009 Jun; 66(6):617-26. PubMed ID: 19487626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salivary cortisol levels in persons with and without different anxiety disorders.
    Vreeburg SA; Zitman FG; van Pelt J; Derijk RH; Verhagen JC; van Dyck R; Hoogendijk WJ; Smit JH; Penninx BW
    Psychosom Med; 2010 May; 72(4):340-7. PubMed ID: 20190128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Panic attacks and the dexamethasone suppression test.
    Sheehan DV; Claycomb JB; Surman OS; Baer L; Coleman J; Gelles L
    Am J Psychiatry; 1983 Aug; 140(8):1063-4. PubMed ID: 6869593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuro-endocrine aspects of the dexamethasone suppression test in psychiatry.
    Lamberts SW
    Life Sci; 1986 Jul; 39(2):91-5. PubMed ID: 3014253
    [No Abstract]   [Full Text] [Related]  

  • 36. Dexamethasone suppression test in schizophrenic patients: report from India.
    Joseph S; Kulhara P; Dash RJ
    Biol Psychiatry; 1987 Jun; 22(6):792-5. PubMed ID: 3593821
    [No Abstract]   [Full Text] [Related]  

  • 37. Psychological and neuroendocrinological characteristics associated with depressive symptoms in breast cancer patients at the initial cancer diagnosis.
    Seok JH; Kim LS; Hong N; Hong HJ; Kim SJ; Kang HJ; Jon DI
    Gen Hosp Psychiatry; 2010; 32(5):503-8. PubMed ID: 20851271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications.
    Uhde TW; Joffe RT; Jimerson DC; Post RM
    Biol Psychiatry; 1988 Mar; 23(6):575-85. PubMed ID: 2833321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Raised blood albumin levels are associated with trait anxiety.
    Stones A; Groome D; Clow A; Hucklebridge F
    Depress Anxiety; 1996-1997; 4(3):151-2. PubMed ID: 9166646
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of treatment on plasma cortisol and dexamethasone.
    Carson SW; Halbreich U
    Biol Psychiatry; 1987 Feb; 22(2):213-6. PubMed ID: 3814671
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.